Drug Patent List
Litigation OpportunitiesNew
Newsletter
Weekly Digest

Pharsight

Atopica Patent Expiration

Atopica Petitions

Details of Atopica's suitability petitions are listed below.

Petitioner Action Date of Action Description
Mizner Bioscience, LLC Approved 29 Mar, 2023 The proposed change is for an unencapsulated oral solution ; the RLNAD is approved as gelatin capsules in 10 mg, 25 mg, 50 mg, and 100 mg capsule strengths.
Provetica Animal Health LLC Approved 21 Feb, 2019 The proposed change is for an unencapsulated oral solution ; the RLNAD is approved as gelatin capsules in 10 mg, 25 mg, 50 mg, and 100 mg capsule strengths.
Ceva Animal Health, LLC Approved 15 Mar, 2018 The generic product will differ in dosage form.
Shotwell & Carr, Inc. Approved 01 Aug, 2013 The generic product will differ in dosage form. The RLNAD is approved as gelatin capsules and the proposed generic product is an oral solution .

About Atopica

Atopica is a drug owned by ELANCO US INC. Atopica uses Cyclosporine as the active ingredient.

Active Ingredient:

Atopica uses Cyclosporine as the active ingredient. Check out other Drugs and Companies using Cyclosporine ingredient.